Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Arterial Stiffness in the Heart Disease of CKD.

Zanoli L, Lentini P, Briet M, Castellino P, House AA, London GM, Malatino L, McCullough PA, Mikhailidis DP, Boutouyrie P.

J Am Soc Nephrol. 2019 Jun;30(6):918-928. doi: 10.1681/ASN.2019020117. Epub 2019 Apr 30.

PMID:
31040188
2.

Liver sinusoidal obstruction syndrome associated with trastuzumab emtansine treatment for breast cancer.

Duret-Aupy N, Lagarce L, Blouet A, Kettani S, Conte C, Bourneau-Martin D, Drablier G, Umlil A, Briet M.

Therapie. 2019 Apr 4. pii: S0040-5957(19)30066-6. doi: 10.1016/j.therap.2019.03.010. [Epub ahead of print] No abstract available.

PMID:
31023619
3.

Impact of Infection Status and Cyclosporine on Voriconazole Pharmacokinetics in an Experimental Model of Cerebral Scedosporiosis.

Lelièvre B, Briet M, Godon C, Legras P, Riou J, Vandeputte P, Diquet B, Bouchara JP.

J Pharmacol Exp Ther. 2018 May;365(2):408-412. doi: 10.1124/jpet.117.245449. Epub 2018 Feb 28.

PMID:
29491040
4.

Reversal of Arterial Stiffness and Maladaptative Arterial Remodeling After Kidney Transplantation.

Karras A, Boutouyrie P, Briet M, Bozec E, Haymann JP, Legendre C, McMahon LP, Delahousse M.

J Am Heart Assoc. 2017 Sep 9;6(9). pii: e006078. doi: 10.1161/JAHA.117.006078.

5.

Arterial Stiffness and Chronic Kidney Disease.

Garnier AS, Briet M.

Pulse (Basel). 2016 Apr;3(3-4):229-41. doi: 10.1159/000443616. Epub 2016 Mar 1.

6.

Hepatocyte nuclear factor-4 alpha in noise-induced cochlear neuropathy.

Groth JB, Kao SY, Briët MC, Stankovic KM.

Dev Neurobiol. 2016 Dec;76(12):1374-1386. doi: 10.1002/dneu.22399. Epub 2016 May 9.

7.

Aldosterone-Induced Vascular Remodeling and Endothelial Dysfunction Require Functional Angiotensin Type 1a Receptors.

Briet M, Barhoumi T, Mian MOR, Coelho SC, Ouerd S, Rautureau Y, Coffman TM, Paradis P, Schiffrin EL.

Hypertension. 2016 May;67(5):897-905. doi: 10.1161/HYPERTENSIONAHA.115.07074. Epub 2016 Apr 4.

8.

Deficiency of T-regulatory cells exaggerates angiotensin II-induced microvascular injury by enhancing immune responses.

Mian MO, Barhoumi T, Briet M, Paradis P, Schiffrin EL.

J Hypertens. 2016 Jan;34(1):97-108. doi: 10.1097/HJH.0000000000000761.

PMID:
26630215
9.

Preclinical validation of anti-nuclear factor-kappa B therapy to inhibit human vestibular schwannoma growth.

Dilwali S, Briët MC, Kao SY, Fujita T, Landegger LD, Platt MP, Stankovic KM.

Mol Oncol. 2015 Aug;9(7):1359-70. doi: 10.1016/j.molonc.2015.03.009. Epub 2015 Mar 31.

10.

Large artery stiffness and hypertension after antiangiogenic drugs: influence on cancer progression.

Alivon M, Giroux J, Briet M, Goldwasser F, Laurent S, Boutouyrie P.

J Hypertens. 2015 Jun;33(6):1310-7. doi: 10.1097/HJH.0000000000000550.

PMID:
25715093
11.

A novel device for measuring arterial stiffness using finger-toe pulse wave velocity: Validation study of the pOpmètre®.

Alivon M, Vo-Duc Phuong T, Vignon V, Bozec E, Khettab H, Hanon O, Briet M, Halimi JM, Hallab M, Plichart M, Mohammedi K, Marre M, Boutouyrie P, Laurent S.

Arch Cardiovasc Dis. 2015 Apr;108(4):227-34. doi: 10.1016/j.acvd.2014.12.003. Epub 2015 Feb 11.

12.

Erythropoietin-induced hypertension and vascular injury in mice overexpressing human endothelin-1: exercise attenuated hypertension, oxidative stress, inflammation and immune response.

Barhoumi T, Briet M, Kasal DA, Fraulob-Aquino JC, Idris-Khodja N, Laurant P, Paradis P, Schiffrin EL.

J Hypertens. 2014 Apr;32(4):784-94. doi: 10.1097/HJH.0000000000000101.

PMID:
24463938
13.

Mineralocorticoid receptor, the main player in aldosterone-induced large artery stiffness.

Briet M.

Hypertension. 2014 Mar;63(3):442-3. doi: 10.1161/HYPERTENSIONAHA.113.02581. Epub 2013 Dec 2. No abstract available.

PMID:
24296283
14.

[Endovascular renal nerve ablation as a treatment for resistant hypertension].

Monge M, Lorthioir A, Bobrie G, Briet M, Plouin PF, Sapoval M, Azizi M.

J Mal Vasc. 2013 Dec;38(6):367-72. doi: 10.1016/j.jmv.2013.09.002. Epub 2013 Oct 14. French.

PMID:
24135305
15.

Baroreflex sensitivity after kidney transplantation: arterial or neural improvement?

Boutouyrie P, Zanoli L, Briet M, Karras A, Delahousse M.

Nephrol Dial Transplant. 2013 Oct;28(10):2401-3. doi: 10.1093/ndt/gft341. No abstract available.

PMID:
24078637
16.

[Management of resistant hypertension].

Briet M, Bobrie G, Azizi M.

Rev Prat. 2013 May;63(5):681-8. French.

PMID:
23789498
17.

Effects of recombinant human erythropoietin on resistance artery endothelial function in stage 4 chronic kidney disease.

Briet M, Barhoumi T, Mian MO, Sierra C, Boutouyrie P, Davidman M, Bercovitch D, Nessim SJ, Frisch G, Paradis P, Lipman ML, Schiffrin EL.

J Am Heart Assoc. 2013 Apr 12;2(2):e000128. doi: 10.1161/JAHA.113.000128.

18.

Protective role of vascular smooth muscle cell PPARγ in angiotensin II-induced vascular disease.

Marchesi C, Rehman A, Rautureau Y, Kasal DA, Briet M, Leibowitz A, Simeone SM, Ebrahimian T, Neves MF, Offermanns S, Gonzalez FJ, Paradis P, Schiffrin EL.

Cardiovasc Res. 2013 Mar 1;97(3):562-70. doi: 10.1093/cvr/cvs362. Epub 2012 Dec 17.

PMID:
23250918
19.

Treatment of arterial remodeling in essential hypertension.

Briet M, Schiffrin EL.

Curr Hypertens Rep. 2013 Feb;15(1):3-9. doi: 10.1007/s11906-012-0325-0. Review.

PMID:
23250721
20.

Vascular actions of aldosterone.

Briet M, Schiffrin EL.

J Vasc Res. 2013;50(2):89-99. doi: 10.1159/000345243. Epub 2012 Nov 21. Review.

21.

Large artery stiffening and remodeling are independently associated with all-cause mortality and cardiovascular events in chronic kidney disease.

Karras A, Haymann JP, Bozec E, Metzger M, Jacquot C, Maruani G, Houillier P, Froissart M, Stengel B, Guardiola P, Laurent S, Boutouyrie P, Briet M; Nephro Test Study Group.

Hypertension. 2012 Dec;60(6):1451-7. doi: 10.1161/HYPERTENSIONAHA.112.197210. Epub 2012 Oct 22.

PMID:
23090769
22.

Arterial stiffness as surrogate end point: needed clinical trials.

Laurent S, Briet M, Boutouyrie P.

Hypertension. 2012 Aug;60(2):518-22. doi: 10.1161/HYPERTENSIONAHA.112.194456. Epub 2012 Jun 25. Review. No abstract available.

PMID:
22733473
23.

Chronic kidney disease and vascular remodelling: molecular mechanisms and clinical implications.

Briet M, Burns KD.

Clin Sci (Lond). 2012 Oct;123(7):399-416. doi: 10.1042/CS20120074. Review.

PMID:
22671427
24.

Arterial stiffness and pulse pressure in CKD and ESRD.

Briet M, Boutouyrie P, Laurent S, London GM.

Kidney Int. 2012 Aug;82(4):388-400. Review.

25.

Pharmacological modulation of arterial stiffness.

Boutouyrie P, Lacolley P, Briet M, Regnault V, Stanton A, Laurent S, Mahmud A.

Drugs. 2011 Sep 10;71(13):1689-701. doi: 10.2165/11593790-000000000-00000. Review.

PMID:
21902292
26.

Hermann Hesse and L: two narratives of sciatica.

Briët MC, Haan J, Kaptein AA.

Clin Neurol Neurosurg. 2012 Jan;114(1):9-11. doi: 10.1016/j.clineuro.2011.07.011. Epub 2011 Aug 10.

PMID:
21831518
27.

Arterial remodeling associates with CKD progression.

Briet M, Collin C, Karras A, Laurent S, Bozec E, Jacquot C, Stengel B, Houillier P, Froissart M, Boutouyrie P; Nephrotest Study Group.

J Am Soc Nephrol. 2011 May;22(5):967-74. doi: 10.1681/ASN.2010080863. Epub 2011 Apr 14.

28.

Long-term changes in arterial structure and function and left ventricular geometry after enzyme replacement therapy in patients affected with Fabry disease.

Collin C, Briet M, Tran TC, Beaussier H, Benistan K, Bensalah M, Mousseaux E, Froissart M, Bozec E, Laurent S, Boutouyrie P, Germain DP.

Eur J Prev Cardiol. 2012 Feb;19(1):43-54. doi: 10.1177/1741826710391118. Epub 2011 Mar 4.

PMID:
21450622
29.
30.

The role of aldosterone in the metabolic syndrome.

Briet M, Schiffrin EL.

Curr Hypertens Rep. 2011 Apr;13(2):163-72. doi: 10.1007/s11906-011-0182-2. Review.

PMID:
21279740
31.

New potent bisubstrate inhibitors of histone acetyltransferase p300: design, synthesis and biological evaluation.

Kwie FH, Briet M, Soupaya D, Hoffmann P, Maturano M, Rodriguez F, Blonski C, Lherbet C, Baudoin-Dehoux C.

Chem Biol Drug Des. 2011 Jan;77(1):86-92. doi: 10.1111/j.1747-0285.2010.01056.x. Epub 2010 Nov 30.

PMID:
21118378
32.

Aldosterone: effects on the kidney and cardiovascular system.

Briet M, Schiffrin EL.

Nat Rev Nephrol. 2010 May;6(5):261-73. doi: 10.1038/nrneph.2010.30. Epub 2010 Mar 16. Review.

PMID:
20234356
33.

Age-independent association between arterial and bone remodeling in mild-to-moderate chronic kidney disease.

Briet M, Maruani G, Collin C, Bozec E, Gauci C, Boutouyrie P, Houillier P, Laurent S, Froissart M.

Nephrol Dial Transplant. 2010 Jan;25(1):191-7. doi: 10.1093/ndt/gfp373. Epub 2009 Aug 4.

PMID:
19654229
34.

Large and small artery cross-talk and recent morbidity-mortality trials in hypertension.

Laurent S, Briet M, Boutouyrie P.

Hypertension. 2009 Aug;54(2):388-92. doi: 10.1161/HYPERTENSIONAHA.109.133116. Epub 2009 Jun 22. Review. No abstract available.

PMID:
19546376
35.

[The vascular renal diseases].

Belenfant X, Briet M.

Rev Prat. 2008 Nov 30;58(18):2045-50; quiz 2077. French. No abstract available.

PMID:
19143278
36.

Importance of arterial stiffness as cardiovascular risk factor for future development of new type of drugs.

Boutouyrie P, Laurent S, Briet M.

Fundam Clin Pharmacol. 2008 Jun;22(3):241-6. doi: 10.1111/j.1472-8206.2008.00584.x. Review.

PMID:
18485143
37.

Accelerated arterial stiffening and gene expression profile of the aorta in patients with coronary artery disease.

Fassot C, Briet M, Rostagno P, Barbry P, Perret C, Laude D, Boutouyrie P, Bozec E, Bruneval P, Latremouille C, Laurent S.

J Hypertens. 2008 Apr;26(4):747-57. doi: 10.1097/HJH.0b013e3282f4b3d0.

PMID:
18327085
38.

Cardiovascular risk assessment through target organ damage: role of carotid to femoral pulse wave velocity.

Boutouyrie P, Vermersch S, Laurent S, Briet M.

Clin Exp Pharmacol Physiol. 2008 Apr;35(4):530-3. doi: 10.1111/j.1440-1681.2008.04911.x.

PMID:
18307756
39.

Endothelial function and chronic exposure to air pollution in normal male subjects.

Briet M, Collin C, Laurent S, Tan A, Azizi M, Agharazii M, Jeunemaitre X, Alhenc-Gelas F, Boutouyrie P.

Hypertension. 2007 Nov;50(5):970-6. Epub 2007 Sep 17.

PMID:
17875820
40.

New insights into the risk factors for coronary calcifications.

Briet M, Boutouyrie P.

J Hypertens. 2007 Aug;25(8):1576-7. No abstract available.

PMID:
17620951
41.

Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease.

Briet M, Bozec E, Laurent S, Fassot C, London GM, Jacquot C, Froissart M, Houillier P, Boutouyrie P.

Kidney Int. 2006 Jan;69(2):350-7.

42.

How Bartter's and Gitelman's syndromes, and Dent's disease have provided important insights into the function of three renal chloride channels: ClC-Ka/b and ClC-5.

Briet M, Vargas-Poussou R, Lourdel S, Houillier P, Blanchard A.

Nephron Physiol. 2006;103(1):p7-13. Epub 2005 Dec 12. Review.

43.

Selective inhibition of dipeptidyl peptidase I, not caspases, prevents the partial processing of procaspase-3 in CD3-activated human CD8(+) T lymphocytes.

Bidère N, Briet M, Dürrbach A, Dumont C, Feldmann J, Charpentier B, de Saint-Basile G, Senik A.

J Biol Chem. 2002 Aug 30;277(35):32339-47. Epub 2002 Jun 21.

44.

Symptom perception: psychological correlates of symptom reporting and illness behavior of women with medically unexplained gynecological symptoms.

van Vliet KP, Everaerd W, van Zuuren FJ, Lammes FB, Briët M, Kleiverda G, Schutte M.

J Psychosom Obstet Gynaecol. 1994 Sep;15(3):171-81.

PMID:
8000475
45.

Detection of human papillomavirus types by the polymerase chain reaction and the differentiation between high-risk and low-risk cervical lesions.

Cornelissen MT, Bots T, Briët MA, Jebbink MF, Struyk AP, van den Tweel JG, Greer CE, Smits HL, ter Schegget J.

Virchows Arch B Cell Pathol Incl Mol Pathol. 1992;62(3):167-71.

PMID:
1357817
46.

Human papillomavirus type 16 transcripts expressed from viral-cellular junctions and full-length viral copies in CaSki cells and in a cervical carcinoma.

Smits HL, Cornelissen MT, Jebbink MF, van den Tweel JG, Struyk AP, Briët M, ter Schegget J.

Virology. 1991 Jun;182(2):870-3.

PMID:
1850935
47.

Uniformity of the splicing pattern of the E6/E7 transcripts in human papillomavirus type 16-transformed human fibroblasts, human cervical premalignant lesions and carcinomas.

Cornelissen MT, Smits HL, Briët MA, van den Tweel JG, Struyk AP, van der Noordaa J, ter Schegget J.

J Gen Virol. 1990 May;71 ( Pt 5):1243-6.

PMID:
2161056
48.

Localization of human papillomavirus type 16 DNA using the polymerase chain reaction in the cervix uteri of women with cervical intraepithelial neoplasia.

Cornelissen MT, van den Tweel JG, Struyk AP, Jebbink MF, Briët M, van der Noordaa J, ter Schegget JT.

J Gen Virol. 1989 Oct;70 ( Pt 10):2555-62.

PMID:
2552002
49.

Evaluation of different DNA-DNA hybridisation techniques in detection of HPV 16 DNA in cervical smears and biopsies.

Cornelissen MT, van der Velden KJ, Walboomers JM, Briët MA, Smits HL, van der Noordaa J, ter Schegget J.

J Med Virol. 1988 May;25(1):105-14.

PMID:
2842441

Supplemental Content

Support Center